News updates

Revitalizing Traditional Chinese Medicine: Good Medicine for the World

scroll down

Home page

Liangji Dynamic

Company dynamics

Industry News

Notice

Guizhou Liangji Pharmaceutical Co., Ltd. Drug GMP Certification Review Publicity

Release time:

2019-12-11

Author:

Source:

According to the website of the Guizhou Provincial Drug Administration, on December 10, 2019, the Guizhou Provincial Food and Drug Evaluation and Inspection Center issued a Drug GMP Certification Review Notice (No. 163)
According to the Measures for the Administration of Good Manufacturing Practice Certification of Drugs and the Notice on Issuing the Measures for the Administration of Good Manufacturing Practice Certification of Drugs (State Food and Drug Administration [2011] No. 365) issued by the State Food and Drug Administration, after on-site inspection and audit, Guizhou Liangji Pharmaceutical Co., Ltd. complies with the Good Manufacturing Practice of Drugs (revised in 2010) and is now publicly announced. The public notice period is 10 working days, from December 10, 2019 to December 23, 2019.
Catalogue of Drug GMP Certification Review and Publicity of Guizhou Provincial Food and Drug Evaluation and Inspection Center (No. 163)

Acceptance number	Enterprise Name	certification scope	On site inspection time	inspector
GZ20190027	Guizhou Liangji Pharmaceutical Co., Ltd	Hard capsule, granule, granule (A), mixture, syrup, spray, ointment (including Chinese medicine extract)	November 14th to November 16th, 2019	Zhang Yuanrong, Yang Xin, Zhang Yunjie